{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:07:40Z","timestamp":1788880060595,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["800-20210279"],"award-info":[{"award-number":["800-20210279"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00251803"],"award-info":[{"award-number":["RS-2023-00251803"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03666-w","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:17:53Z","timestamp":1762251473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SCRIM score: a clinical tool for cancer risk-stratification in patients with idiopathic inflammatory myopathy"],"prefix":"10.1186","volume":"27","author":[{"given":"Yun Kyu","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yoon","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-2612","authenticated-orcid":false,"given":"Jinhyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-2582","authenticated-orcid":false,"given":"Jun Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"9250","key":"3666_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96\u2013100.","journal-title":"Lancet"},{"issue":"9","key":"3666_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","volume":"55","author":"EH Kang","year":"2016","unstructured":"Kang EH, Lee SJ, Ascherman DP, Lee YJ, Lee EY, Lee EB, et al. Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis. Rheumatology (Oxford). 2016;55(9):1631\u201341.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3666_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","volume":"45","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg O. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. Semin Arthritis Rheum. 2015;45(3):301\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3666_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","volume":"77","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018;77(1):30\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3666_CR5","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","volume":"60","author":"AGS Oldroyd","year":"2021","unstructured":"Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, et al. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021;60(6):2615\u201328.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3666_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42(2):282\u201391.","journal-title":"J Rheumatol"},{"issue":"1","key":"3666_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis. 2018;77(1):40\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3666_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00296-017-3799-x","volume":"37","author":"L Nuno-Nuno","year":"2017","unstructured":"Nuno-Nuno L, Joven BE, Carreira PE, Maldonado-Romero V, Larena-Grijalba C, Cubas IL, et al. Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. Rheumatol Int. 2017;37(11):1853\u201361.","journal-title":"Rheumatol Int"},{"issue":"12","key":"3666_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","volume":"19","author":"AGS Oldroyd","year":"2023","unstructured":"Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, et al. International guideline for idiopathic inflammatory Myopathy-Associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative. Nat Rev Rheumatol. 2023;19(12):805\u201317.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"3666_CR10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European league against Rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3666_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"3666_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"3666_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","volume":"20","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20(3):387\u2013408.","journal-title":"Dermatol Clin"},{"issue":"6","key":"3666_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464\u201374.","journal-title":"Chest"},{"issue":"1","key":"3666_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100\u20139.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"3666_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working G. 224th ENMC international workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, the Netherlands, 14\u201316 October 2016. Neuromuscul Disord. 2018;28(1):87\u201399.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"3666_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Med (Baltim). 2005;84(4):231\u201349.","journal-title":"Med (Baltim)"},{"issue":"3","key":"3666_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4082\/kjfm.22.0052","volume":"43","author":"HT Kang","year":"2022","unstructured":"Kang HT. Current status of the National health screening programs in South Korea. Korean J Fam Med. 2022;43(3):168\u201373.","journal-title":"Korean J Fam Med"},{"key":"3666_CR19","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G. Developing clinical prediction models: a step-by-step guide. BMJ. 2024;386:e078276.","journal-title":"BMJ"},{"key":"3666_CR20","doi-asserted-by":"crossref","unstructured":"Tang IYK, Chan SCW, Li PH, Li TWL, Luk LTH, Chan D et al. Validation of the international myositis assessment and clinical studies group guideline on cancer risk stratification. Rheumatology (Oxford). 2024.","DOI":"10.1093\/rheumatology\/keae504"},{"issue":"8","key":"3666_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","volume":"180","author":"W Liang","year":"2020","unstructured":"Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081\u20139.","journal-title":"JAMA Intern Med"},{"key":"3666_CR22","doi-asserted-by":"crossref","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB, Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23(10):1631\u201360.","DOI":"10.1002\/sim.1742"},{"key":"3666_CR23","unstructured":"KOSIS. Cancer incident cases and incidence rates by site(24 items), sex, age group 2022 [Available from: https:\/\/kosis.kr\/statHtml\/statHtml.do?orgId=117%26;tblId=DT_117N_A00023%26;conn_path=I2%26;language=en"},{"issue":"9","key":"3666_CR24","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/rheumatology\/keae167","volume":"63","author":"A Loganathan","year":"2024","unstructured":"Loganathan A, Gupta L, Rudge A, Lu H, Bowler E, McMorrow F, et al. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the myocite cohort. Rheumatology (Oxford). 2024;63(9):2363\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"3666_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41927-020-00132-9","volume":"4","author":"F To","year":"2020","unstructured":"To F, Ventin-Rodriguez C, Elkhalifa S, Lilleker JB, Chinoy H. Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results. BMC Rheumatol. 2020;4:28.","journal-title":"BMC Rheumatol"},{"key":"3666_CR26","doi-asserted-by":"publisher","first-page":"106581","DOI":"10.1016\/j.rmed.2021.106581","volume":"187","author":"AS Jee","year":"2021","unstructured":"Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, et al. Diagnosis of myositis-associated interstitial lung disease: utility of the myositis autoantibody line immunoassay. Respir Med. 2021;187:106581.","journal-title":"Respir Med"},{"issue":"1","key":"3666_CR27","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/RHU.0000000000002043","volume":"30","author":"CW Tseng","year":"2024","unstructured":"Tseng CW, Satoh M, Hasegawa T, Tanaka S, Chen YM. Analytic and clinical validity of Myositis-Specific antibodies by Line-Blot immunoassay is essential. J Clin Rheumatol. 2024;30(1):e23\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"3666_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/1756-185X.14046","volume":"24","author":"Y Li","year":"2021","unstructured":"Li Y, Jia X, Sun X, Shi L, Lin F, Gan Y, et al. Risk factors for cancer-associated myositis: A large-scale multicenter cohort study. Int J Rheum Dis. 2021;24(2):268\u201373.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"3666_CR29","doi-asserted-by":"publisher","first-page":"e15198","DOI":"10.1111\/1756-185X.15198","volume":"27","author":"I Teh","year":"2024","unstructured":"Teh I, Huang V, Oon S, Day J. Real-world implications of IMACS malignancy screening guidelines for idiopathic inflammatory myopathies: an evaluation of compliance and economic impact at a tertiary referral center. Int J Rheum Dis. 2024;27(5):e15198.","journal-title":"Int J Rheum Dis"},{"key":"3666_CR30","doi-asserted-by":"publisher","first-page":"151940","DOI":"10.1016\/j.semarthrit.2021.12.008","volume":"53","author":"E Trallero-Araguas","year":"2022","unstructured":"Trallero-Araguas E, Gil-Vila A, Martinez-Gomez X, Pinal-Fernandez I, Alvarado-Cardenas M, Simo-Perdigo M, et al. Cancer screening in idiopathic inflammatory myopathies: ten years experience from a single center. Semin Arthritis Rheum. 2022;53:151940.","journal-title":"Semin Arthritis Rheum"},{"key":"3666_CR31","doi-asserted-by":"publisher","first-page":"152107","DOI":"10.1016\/j.semarthrit.2022.152107","volume":"57","author":"G Bentick","year":"2022","unstructured":"Bentick G, Fairley J, Nadesapillai S, Wicks I, Day J. Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review. Semin Arthritis Rheum. 2022;57:152107.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3666_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/art.42311","volume":"75","author":"CA Mecoli","year":"2023","unstructured":"Mecoli CA, Igusa T, Chen M, Wang X, Albayda J, Paik JJ, et al. Subsets of idiopathic inflammatory myositis enriched for contemporaneous cancer relative to the general population. Arthritis Rheumatol. 2023;75(4):620\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3666_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","volume":"59","author":"J De Vooght","year":"2020","unstructured":"De Vooght J, Vulsteke JB, De Haes P, Bossuyt X, Lories R, De Langhe E. Anti-TIF1-gamma autoantibodies: warning lights of a tumour autoantigen. Rheumatology (Oxford). 2020;59(3):469\u201377.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3666_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/1346-8138.15284","volume":"47","author":"N Ikeda","year":"2020","unstructured":"Ikeda N, Yamaguchi Y, Kanaoka M, Ototake Y, Akita A, Watanabe T, et al. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-gamma antibody in patients with dermatomyositis. J Dermatol. 2020;47(5):490\u20136.","journal-title":"J Dermatol"},{"key":"3666_CR35","doi-asserted-by":"publisher","first-page":"152011","DOI":"10.1016\/j.semarthrit.2022.152011","volume":"55","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yang H, Yang H, Liu H, Tian X, Jiang W, et al. Serum levels of anti-transcriptional intermediary factor 1-gamma autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis. Semin Arthritis Rheum. 2022;55:152011.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3666_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, et al. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther. 2017;19(1):259.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3666_CR37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012;71(5):710\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3666_CR38","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum. 2013;65(11):2954\u201362.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03666-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:17:55Z","timestamp":1762251475000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03666-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03666-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of each center (Seoul National University Hospital, Seoul National University Bundang Hospital, Boramae Medical Center, and Chungnam National University Hospital). The requirement for patient consent was waived because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}